Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…
Medicines regulator amends conflict of interest rules to ensure suitability of experts The European Medicines Agency has amended its policy on handling declarations of interest to ensure pharmaceutical experts are not unduly excluded.…
EllaOne to be available without prescriptionEllaOne (ulipristal acetate), an emergency contraceptive, is to be made available without a prescription from community pharmacies throughout the European Union.…
UK bill aims to allow off-patent drugs to be licensed for new purposes A bill going through Parliament wants the National Institute for Health and Care Excellence (NICE) to appraise off-patent drugs to allow them to be used for new indications.…
UK medicines regulator appoints Michael Rawlins as chairmanThe Medicines and Healthcare products Regulatory Agency has appointed Michael Rawlins as its chairman from 1 December 2014.…
First drug for rare sun disease recommended for approval in Europe The European Medicines Agency recommends that Scenesse (afamelanotide) should be approved for the prevention of severe sunburn in patients with erythropoietic protoporphyria.…
Cancer drugs approved faster in the United States than in Europe or Canada Regulatory agencies in the United States take less time to approve new cancer drugs than those in Europe or Canada, according to new research.…
Big tobacco’s nicotine inhaler approved by UK regulator A cigarette-shaped nicotine inhaler has become the first of its kind to be licensed by the UK Medicines and Healthcare products Regulatory Agency.…
